# Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

> **NCT00390299** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 23 (actual)

## Conditions studied

- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma
- Mixed Glioma
- Recurrent Glioblastoma

## Interventions

- **BIOLOGICAL:** Carcinoembryonic Antigen-Expressing Measles Virus
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT00390299
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-23
- **Primary completion:** 2018-11-29
- **Final completion:** 2019-11-30
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00390299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00390299, "Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00390299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*